The 14-year-old patient was brought to Ankura Hospital in Gachibowli, suffering from persistent headaches that had been ...

There's been a rise in young and middle-aged U.S. adults experiencing catastrophic brain bleeds. A neurologist explains the ...

AstraZeneca and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced long-term results ...

Updated results from the OlympiA Phase III trial showed AstraZeneca and Merck & Co., Inc's, known as MSD outside of the US and Canada, LYNPARZA® (olaparib) demonstrated sustained, clinically ...